Home
  • Listserves
  • Main Areas of Work
  • Support KEI
  • Events
  • Publications
  • Blogs
  • About KEI

Knowledge Ecology International

Attending and mending the knowledge ecosystem

Navigation

  • Site Map
  • Recent posts
  • Feed aggregator
  • Polls
  • Groups

Round II of the Paris Accord took place in Paris on October 23 and 24, 2009.

Books

  • Right to Read for Persons with Reading Disabilities
  • About KEI
  • Access to Medical Technologies
  • Competition Policy
  • Data points on price of medical technologies
  • Enforcement and Remedies to Infringement
  • Events
  • General Access to Knowledge Issues
  • Knowledge Governance Fora
  • Main Areas of Work
  • Nuclear Proliferation
  • Patent Policy
  • Prizes to stimulate innovation
    • Why is there resistance to prize funds?
    • Prizes and Grants, Type I, II and III diseases, rich and poor countries, open and closed medicine development
    • The Carbon Dioxide Capture Technology Prize
    • Transparency, cost benefit analysis and de-linkage of cost of R&D from price of the products for Rare and Neglected Pediatric Diseases
    • The Health Impact Fund Proposal
      • Why the HIF rejected open licensing
  • Publications
  • Transparency

User login

What is OpenID?
  • Log in using OpenID
  • Cancel OpenID login
  • Create new account
  • Request new password
Home » Prizes to stimulate innovation

The Health Impact Fund Proposal

  • View
  • What links here
  • WHO/IGWG

Selected KEI 2008 Blogs on the Health Impact Fund

  • April 27, 2008. Open licensing vs Monopoly Controlled Supply
  • November 17, 2008. The Health Impact Fund and product monopolies
  • November 18, 2008.HIF on Intellectual Property
  • November 18, 2008. Excerpts from HIF: compulsory licensing
  • November 18, 2008. HIF on the Sanders prize fund bill
  • November 19, 2008. Why the HIF rejected open licensing
  • November 20, 2008. Impact of the HIF on generic industry in developing countries
  • November 27, 2008. Pogge and Hollis on the Trade-off between access and incentives
  • November 28, 2008. HIF on why voluntary licensing of patents is not required
  • December 2, 2008. Blogging the Washington DC HIF presentation
  • December 3, 2008. HIF proposes $600 million annual budget to evaluate health impacts
  • Why the HIF rejected open licensing
‹ Transparency, cost benefit analysis and de-linkage of cost of R&D from price of the products for Rare and Neglected Pediatric Diseases up Why the HIF rejected open licensing ›
  • Printer-friendly version
  • Send to friend

Support KEI

WASHINGTON 1621 Connecticut Ave. NW, Suite 500, Washington, DC 20009 /TEL: +1.202.332.2670 · FAX +1.202.332.2673 GENEVE 1 Route des Morillons, CP 2100, 1211 Genève 2, Switzerland TEL: +41.22.791.6727
THEME DESIGN Copyright © 2009 under GPL by Tribute Media. Site Powered by Drupal.